India approves emergency use of remdesivir to treat COVID-19 patients - (This is Money via NewsPoints Desk)

  • The Drugs Controller General of India said Gilead Sciences' remdesivir has been approved in India for emergency use in treating COVID-19 patients, as reported in This is Money.

  • The antiviral drug was granted emergency use authorization by the FDA last month and has also received approval by Japanese health regulators.

To read more NewsPoints articles, click here.